Smallwood Wealth Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108K Sell
4,500
-404
-8% -$10.6K 0.05% 132
2026
Q1
$138K Hold
4,904
0.07% 99
2025
Q4
$122K Sell
4,904
-200
-4% -$5.04K 0.06% 107
2025
Q3
$130K Sell
5,104
-500
-9% -$12.3K 0.07% 107
2025
Q2
$136K Hold
5,604
0.08% 97
2025
Q1
$142K Buy
+5,604
New +$147K 0.09% 88
2024
Q3
Sell
-7,416
Closed -$207K 74
2024
Q2
$207K Sell
7,416
-598
-7% -$16.5K 0.16% 65
2024
Q1
$222K Buy
8,014
+602
+8% +$16.7K 0.17% 62
2023
Q4
$213K Sell
7,412
-61
-0.8% -$1.84K 0.18% 62
2023
Q3
$248K Buy
7,473
+502
+7% +$17.8K 0.23% 56
2023
Q2
$256K Buy
6,971
+558
+9% +$21.7K 0.23% 55
2023
Q1
$262K Sell
6,413
-411
-6% -$17.8K 0.25% 53
2022
Q4
$350K Buy
6,824
+18
+0.3% +$863 0.3% 52
2022
Q3
$298K Buy
6,806
+126
+2% +$6.12K 0.27% 59
2022
Q2
$350K Sell
6,680
-22
-0.3% -$1.12K 0.35% 47
2022
Q1
$347K Hold
6,702
0.33% 42
2021
Q4
$396K Buy
+6,702
New +$332K 0.37% 40

Other funds holding PFE

Smallwood Wealth Investment Management's PFE Position: Q2 2026 in Review

Smallwood Wealth Investment Management reduced its Pfizer (PFE) stake by 8.2% in Q2 2026, selling an estimated $10.6K and leaving 4,500 shares worth $108K. The position accounts for 0.05% of the portfolio, ranked #132.

Smallwood Wealth Investment Management first reported a position in PFE in Q4 2021 and has held it in 17 quarters since. The position peaked at $396K in Q4 2021. 990 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Smallwood Wealth Investment Management held 4,500 shares of Pfizer worth $108K as of Q2 2026.
  • Smallwood Wealth Investment Management sold 404 Pfizer shares in Q2 2026, an estimated $10.6K.
  • Pfizer made up 0.05% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #132 holding.
  • Smallwood Wealth Investment Management first reported a position in Pfizer in Q4 2021 and has held it in 17 quarters since.
  • Smallwood Wealth Investment Management's Pfizer position peaked at $396K in Q4 2021.
  • 990 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.